CCL22 regulates experimental autoimmune encephalomyelitis by controlling inflammatory macrophage accumulation and effector function

Journal of Leukocyte Biology

Volumn 89, Issue 1, 2011, Pages 93-104

  Dogan, Rukiye Nazan E ^a   Long, Nancy ^a   Forde, Eileen ^a   Dennis, Kristen ^a   Kohm, Adam P ^a   Miller, Stephen D ^a   Karpus, William J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Autoimmunity; CNS; EAE; Migration; Multiple sclerosis; Trafficking

Indexed keywords

CD11B ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; MACROPHAGE DERIVED CHEMOKINE; TUMOR NECROSIS FACTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL POPULATION; CELL PROLIFERATION; CELL TRANSFER; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; DISEASE SEVERITY; EFFECTOR CELL; FEMALE; GENE EXPRESSION; IN VITRO STUDY; LEUKOCYTE; MACROPHAGE; MOUSE; NONHUMAN; PATHOLOGY; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, NEUTRALIZING; CENTRAL NERVOUS SYSTEM; CHEMOKINE CCL22; DISEASE PROGRESSION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EPITOPES; FEMALE; INFLAMMATION; LYMPHOCYTE COUNT; MACROPHAGES; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES, REGULATORY;

MUS;

EID: 79251580358     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0810442     Document Type: Article

References (60)

1. Hohlfeld, R., Kerschensteiner, M., Stadelmann, C., Lassmann, H., Wekerle, H. (2000) The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis. J. Neuroimmunol. 107, 161-166. (Pubitemid 30347422)
2. + T cell cytokine profile in experimental allergic encephalomyelitis. Eur. J. Immunol. 27, 2840-2847.
3. Hickey, W. F., Hsu, B. L., Kimura, H. (1991) T-lymphocyte entry into the central nervous system. J. Neurosci. Res. 28, 254-260.
4. 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis. Lab. Invest. 63, 162-170.
5. Hickey, W. F. (1991) Migration of hematogenous cells through the blood-brain barrier and the initiation of CNS inflammation. Brain Pathol. 1, 97-105.
6. Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., Kuchroo, V. K. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235-238.
7. Tuohy, V. K., Sobel, R. A., Lu, Z., Laursen, R. A., Lees, M. B. (1992) Myelin proteolipid protein: minimum sequence requirements for active induction of autoimmune encephalomyelitis in SWR/J and SJL/J mice. J. Neuroimmunol. 39, 67-74.
8. Kuchroo, V. K., Sobel, R. A., Laning, J. C., Martin, C. A., Greenfield, E., Dorf, M. E., Lees, M. B. (1992) Experimental allergic encephalomyelitis mediated by cloned T cells specific for a synthetic peptide of myelin proteolipid protein. Fine specificity and T cell receptor Vβ usage. J. Immunol. 148, 3776-3782.
9. Whitham, R. H., Bourdette, D. N., Hashim, G. A., Herndon, R. M., Ilg, R. C., Vandenbark, A. A., Offner, H. (1991) Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis. J. Immunol. 146, 101-107.
10. Brosnan, C. F., Bornstein, M. B., Bloom, B. R. (1981) The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis. J. Immunol. 126, 614-620. (Pubitemid 11136722)
11. Huitinga, I., Van Rooijen, N., De Groot, C. J. A., Uitdehaag, B. M. J., Dijkstra, C. D. (1990) Suppression of experimental allergic encephalomyelitis in Lewis rat after elimination of macrophages. J. Exp. Med. 172, 1025-1033.
12. Dogan, R. N., Elhofy, A., Karpus, W. J. (2008) Production of CCL2 by central nervous system cells regulates development of murine experimental autoimmune encephalomyelitis through the recruitment of TNF- and iNOS-expressing macrophages and myeloid dendritic cells. J. Immunol. 180, 7376-7384.
13. Murphy, P. M., Baggiolini, M., Charo, I. F., Hebert, C. A., Horuk, R., Matsushima, K., Miller, L. H., Oppenheim, J. J., Power, C. A. (2000) International Union of Pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52, 145-176.
14. Zlotnik, A., Yoshie, O. (2000) Chemokines: a new classification system and their role in immunity. Immunity 12, 121-127.
15. Karpus, W. J., Fife, B. T., Kennedy, K. J. (2003) Immunoneutralization of chemokines for the prevention and treatment of central nervous system autoimmune disease. Methods 29, 362-368.
16. Karpus, W. J., Ransohoff, R. M. (1998) Chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease pathogenesis. J. Immunol. 161, 2667-2671.
17. Chang, M. s., McNinch, J., Elias Iii, C., Manthey, C. L., Grosshans, D., Meng, T., Boone, T., Andrew, D. P. (1997) Molecular cloning and functional characterization of a novel CC chemokine, stimulated T cell chemotactic protein (STCP-1) that specifically acts on activated T lymphocytes. J. Biol. Chem. 272, 25229-25237.
18. Imai, T., Chantry, D., Raport, C. J., Wood, C. L., Nishimura, M., Godiska, R., Yoshie, O., Gray, P. W. (1998) Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4. J. Biol. Chem. 273, 1764-1768. (Pubitemid 28133708)
19. Chantry, D., Romagnani, P., Raport, C. J., Wood, C. L., Epp, A., Romagnani, S., Gray, P. W. (1999) Macrophage-derived chemokine is localized to thymic medullary epithelial cells and is a chemoattractant for CD3+, CD4+, CD8low thymocytes. Blood 94, 1890-1898.
20. Andrew, D. P., Chang, M. S., McNinch, J., Wathen, S. T., Rihanek, M., Tseng, J., Spellberg, J. P., Elias, C. G. (1998) STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13. J. Immunol. 161, 5027-5038.
21. Iellem, A., Mariani, M., Lang, R., Recalde, H., Panina-Bordignon, P., Sinigaglia, F., D'Ambrosio, D. (2001) Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4+CD25+ regulatory T cells. J. Exp. Med. 194, 847-853.
22. Gonzalo, J. A., Pan, Y., Lloyd, C. M., Jia, G. Q., Yu, G., Dussault, B., Powers, C. A., Proudfoot, A. E., Coyle, A. J., Gearing, D., Gutierrez-Ramos, J. C. (1999) Mouse monocyte-derived chemokine is involved in airway hyperreactivity and lung inflammation. J. Immunol. 163, 403-411.
23. Kakinuma, T., Nakamura, K., Wakugawa, M., Mitsui, H., Tada, Y., Saeki, H., Torii, H., Komine, M., Asahina, A., Tamaki, K. (2002) Serum macrophage-derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis. Clin. Exp. Immunol. 127, 270-273.
24. Vestergaard, C., Yoneyama, H., Murai, M., Nakamura, K., Tamaki, K., Terashima, Y., Imai, T., Yoshie, O., Irimura, T., Mizutani, H., Matsushima, K. (1999) Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J. Clin. Invest. 104, 1097-1105. (Pubitemid 29536320)
25. van den Berg, A., Visser, L., Poppema, S. (1999) High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma. Am. J. Pathol. 154, 1685-1691. (Pubitemid 29262850)
26. Chvatchko, Y., Hoogewerf, A. J., Meyer, A., Alouani, S., Juillard, P., Buser, R., Conquet, F., Proudfoot, A. E., Wells, T. N., Power, C. A. (2000) A key role for CC chemokine receptor 4 in lipopolysaccharide-induced endotoxic shock. J. Exp. Med. 191, 1755-1764. (Pubitemid 30331572)
27. Katschke Jr., K. J., Rottman, J. B., Ruth, J. H., Qin, S., Wu, L., LaRosa, G., Ponath, P., Park, C. C., Pope, R. M., Koch, A. E. (2001) Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis. Arthritis Rheum. 44, 1022-1032.
28. Jones, D., O'Hara, C., Kraus, M. D., Perez-Atayde, A. R., Shahsafaei, A., Wu, L., Dorfman, D. M. (2000) Expression pattern of T-cell-associated chemokine receptors and their chemokines correlates with specific subtypes of T-cell non-Hodgkin lymphoma. Blood 96, 685-690.
29. Kim, S. H., Cleary, M. M., Fox, H. S., Chantry, D., Sarvetnick, N. (2002) CCR4-bearing T cells participate in autoimmune diabetes. J. Clin. Invest. 110, 1675-1686.
30. Columba-Cabezas, S., Serafini, B., Ambrosini, E., Sanchez, M., Penna, G., Adorini, L., Aloisi, F. (2002) Induction of macrophage-derived chemokine/CCL22 expression in experimental autoimmune encephalomyelitis and cultured microglia: implications for disease regulation. J. Neuroimmunol. 130, 10-21.
31. Galimberti, D., Fenoglio, C., Comi, C., Scalabrini, D., De Riz, M., Leone, M., Venturelli, E., Cortini, F., Piola, M., Monaco, F., Bresolin, N., Scarpini, E. (2008) MDC/CCL22 intrathecal levels in patients with multiple sclerosis. Mult. Scler. 14, 547-549.
32. Karpus, W. J., Lukacs, N. W., McRae, B. L., Strieter, R. M., Kunkel, S. L., Miller, S. D. (1995) An important role for the chemokine macrophage inflammatory protein-1α in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J. Immunol. 155, 5003-5010.
33. Miller, S. D., Karpus, W. J. (2007) Experimental autoimmune encephalomyelitis in the mouse. Curr. Protoc. Immunol. Chapter 15, Unit 15.1.
34. Pope, J. G., Karpus, W. J., VanderLugt, C., Miller, S. D. (1996) Flow cytometric and functional analyses of central nervous system-infiltrating cells in SJL/J mice with Theiler's virus- induced demyelinating disease. Evidence for a CD4 + T cell-mediated pathology. J. Immunol. 156, 4050-4058.
35. Hendrzak, J. A., Wallace, P. D., Morahan, P. S. (1994) Optimizing the detection of cell surface antigens on elicited or activated mouse peritoneal macrophages. Cytometry 17, 349-356.
36. Karpus, W. J., Kennedy, K. J., Smith, W. S., Miller, S. D. (1996) Inhibition of relapsing experimental autoimmune encephalomyelitis in SJL mice by feeding the immunodominant PLP139-151 peptide. J. Neurosci. Res. 45, 410-423.
37. Karpus, W. J., Kennedy, K. J., Kunkel, S. L., Lukacs, N. W. (1998) Monocyte chemotactic protein 1 regulates oral tolerance induction by inhibition of T helper cell 1-related cytokines. J. Exp. Med. 187, 733-741.
38. Kennedy, K. J., Strieter, R. M., Kunkel, S. L., Lukacs, N. W., Karpus, W. J. (1998) Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1α and monocyte chemotactic protein-1. J. Neuroimmunol. 92, 98-108.
39. Trujillo, G., O'Connor, E. C., Kunkel, S. L., Hogaboam, C. M. (2008) A novel mechanism for CCR4 in the regulation of macrophage activation in bleomycin-induced pulmonary fibrosis. Am. J. Pathol. 172, 1209-1221.
40. Yogo, Y., Fujishima, S., Inoue, T., Saito, F., Shiomi, T., Yamaguchi, K., Ishizaka, A. (2009) Macrophage derived chemokine (CCL22), thymus and activation-regulated chemokine (CCL17), and CCR4 in idiopathic pulmonary fibrosis. Respir. Res. 10, 80.
41. King, I. L., Dickendesher, T. L., Segal, B. M. (2009) Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. Blood 113, 3190-3197.
42. Ishii, M., Hogaboam, C. M., Joshi, A., Ito, T., Fong, D. J., Kunkel, S. L. (2008) CC chemokine receptor 4 modulates Toll-like receptor 9-mediated innate immunity and signaling. Eur. J. Immunol. 38, 2290-2302.
43. Cardona, A. E., Li, M., Liu, L., Savarin, C., Ransohoff., R. M. (2008) Chemokines in and out of the central nervous system: much more than chemotaxis and inflammation. J. Leukoc. Biol. 84, 587-594.
44. Savarin-Vuaillat, C., Ransohoff, R. M. (2007) Chemokines and chemokine receptors in neurological disease: raise, retain, or reduce? Neurotherapeutics 4, 590-601.
45. Andrew, D. P., Ruffing, N., Kim, C. H., Miao, W., Heath, H., Li, Y., Murphy, K., Campbell, J. J., Butcher, E. C., Wu, L. (2001) C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential. J. Immunol. 166, 103-111.
46. Freeman, C. M., Stolberg, V. R., Chiu, B. C., Lukacs, N. W., Kunkel, S. L., Chensue, S. W. (2006) CCR4 participation in Th type 1 (mycobacterial) and Th type 2 (schistosomal) anamnestic pulmonary granulomatous responses. J. Immunol. 177, 4149-4158.
47. Lee, I., Wang, L., Wells, A. D., Dorf, M. E., Ozkaynak, E., Hancock, W. W. (2005) Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J. Exp. Med. 201, 1037-1044.
48. Meyer, E. H., Wurbel, M-A., Staton, T. L., Pichavant, M., Kan, M. J., Savage, P. B., DeKruyff, R. H., Butcher, E. C., Campbell, J. J., Umetsu, D. T. (2007) iNKT cells require CCR4 to localize to the airways and to induce airway hyperreactivity. J. Immunol. 179, 4661-4671.
49. Karpus, W. J., Lukacs, N. W., Kennedy, K. J., Smith, W. S., Hurst, S. D., Barrett, T. A. (1997) Differential CC chemokine-induced enhancement of T helper cell cytokine production. J. Immunol. 158, 4129-4136.
50. Lukacs, N. W., Chensue, S. W., Karpus, W. J., Lincoln, P., Keefer, C., Strieter, R. M., Kunkel, S. L. (1997) C-C chemokines differentially alter interleukin-4 production from lymphocytes. Am. J. Pathol. 150, 1861-1868.
51. Gu, L., Tseng, S., Horner, R. M., Tam, C., Loda, M., Rollins, B. J. (2000) Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404, 407-411.
52. Fife, B. T., Paniagua, M. C., Lukacs, N. W., Kunkel, S. L., Karpus, W. J. (2001) Selective CC chemokine receptor expression by central nervous system-infiltrating encephalitogenic T cells during experimental autoimmune encephalomyelitis. J. Neurosci. Res. 66, 705-714. (Pubitemid 33032340)
53. Getts, D. R., Terry, R. L., Getts, M. T., Muller, M., Rana, S., Shrestha, B., Radford, J., Van Rooijen, N., Campbell, I. L., King, N. J. (2008) Ly6c+ "inflammatory monocytes" are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis. J. Exp. Med. 205, 2319-2337.
54. Hatakeyama, S., Iwabuchi, K., Ogasawara, K., Good, R. A., Onoe, K. (1994) The murine c-fgr gene product associated with Ly6C and p70 integral membrane protein is expressed in cells of a monocyte/macrophage lineage. Proc. Natl. Acad. Sci. USA 91, 3458-3462. (Pubitemid 24130256)
55. Serbina, N. V., Hohl, T. M., Cherny, M., Pamer, E. G. (2009) Selective expansion of the monocytic lineage directed by bacterial infection. J. Immunol. 183, 1900-1910.
56. Tierney, J. B., Kharkrang, M., La Flamme, A. C. (2009) Type II-activated macrophages suppress the development of experimental autoimmune encephalomyelitis. Immunol. Cell Biol. 87, 235-240.
57. Prinz, M., Garbe, F., Schmidt, H., Mildner, A., Gutcher, I., Wolter, K., Piesche, M., Schroers, R., Weiss, E., Kirschning, C. J., Rochford, C. D., Brück, W., Becher, B. (2006) Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J. Clin. Invest. 116, 456-464. (Pubitemid 43228363)
58. Fife, B. T., Kennedy, K. J., Paniagua, M. C., Lukacs, N. W., Kunkel, S. L., Luster, A. D., Karpus, W. J. (2001) CXCL10 (IFN-γ-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis. J. Immunol. 166, 7617-7624.
59. Fife, B. T., Huffnagle, G. B., Kuziel, W. A., Karpus, W. J. (2000) CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 192, 899-905.
60. Buntinx, M., Hermans, B., Goossens, J., Moechars, D., Gilissen, R. A., Doyon, J., Boeckx, S., Coesemans, E., Vanlommen, G., Van Wauwe, J. P. (2008) Pharmacological profile of JNJ-27141491, a non-competitive and orally active antagonist of the human chemokine receptor CCR2. J. Pharmacol. Exp. Ther. 327, 1-9.